InStride Health
Unknown, US · 3 known investors
InStride provides virtual specialty care for young people ages 7 to 24 with anxiety, OCD, and related disorders, using evidence-based treatment enhanced by AI technology. The company works with insurance providers, referring physicians, and employers to make specialized mental health care more accessible and effective.
Founders & leadership
MP
Mona PotterClinical Co-founder, MD
KB
Kathryn BogerClinical Co-founder, Ph.D., ABPP
Investors · 3
In the news
- Telemedicine Market: 65 Funding Deals (Full List 2024-2026) (2026) – New Market Pitchnewmarketpitch.com · 2026
- InStride Raises $30M to Scale Pediatric Mental Health Support - MedCity Newsmedcitynews.com · 2026
- InStride Health Raises $30M Series C for Pediatric Anxiety Care - TAMradar Funding Rounds Signalstamradar.com · 2026
- InStride Health lands $30M series C to expand pediatric mental health servicesfiercehealthcare.com · 2026
- InStride Health Raises Oversubscribed $30 Million Series B to Expand Access to Best-In-Class Specialty Treatment for Pediatric Anxiety and OCD - Instride Healthcanary.instride.health · 2024
- InStride Health Raises $26M for Virtual Pediatric Behavioral Health Platform, Inks Deal with McLean Hospital - Behavioral Health Businessbhbusiness.com · 2022